Bind Biosciences, Inc.
12Patents
12Active
12Granted
52Portfolio score
Filing activity: Mar 31, 2008 → Dec 17, 2012 · 6 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8734846B2 | Methods for the preparation of targeting agent functionalized diblock copolymers for use in fabrication of therapeutic targeted nanoparticles | Human Necessities | 130 | Active |
| US8420123B2 | Drug loaded polymeric nanoparticles and methods of making and using same | Emerging Cross-Sectional Technologies | 113 | Active |
| US8246968B2 | Cancer cell targeting using nanoparticles | Emerging Cross-Sectional Technologies | 89 | Active |
| US8211473B2 | Stable formulations for lyophilizing therapeutic particles | Emerging Cross-Sectional Technologies | 62 | Active |
| US8206747B2 | Drug loaded polymeric nanoparticles and methods of making and using same | Emerging Cross-Sectional Technologies | 62 | Active |
| US8273363B2 | Cancer cell targeting using nanoparticles | Emerging Cross-Sectional Technologies | 57 | Active |
| US8236330B2 | Cancer cell targeting using nanoparticles | Emerging Cross-Sectional Technologies | 55 | Active |
| US8318211B2 | Therapeutic polymeric nanoparticles comprising vinca alkaloids and methods of making and using same | Human Necessities | 44 | Active |
| US8318208B1 | Drug loaded polymeric nanoparticles and methods of making and using same | Emerging Cross-Sectional Technologies | 43 | Active |
| US8293276B2 | Drug loaded polymeric nanoparticles and methods of making and using same | Emerging Cross-Sectional Technologies | 37 | Active |
| US8357401B2 | Stable formulations for lyophilizing therapeutic particles | Emerging Cross-Sectional Technologies | 28 | Active |
| US8846077B2 | High throughput fabrication of nanoparticles | Emerging Cross-Sectional Technologies | 8 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.